Back to Peptide Library
Cognitive Peptide Bioregulator

Pinealon

Glu-Asp-Arg • EDR Tripeptide

Pinealon is a synthetic tripeptide studied for neural and oxidative-stress signaling. Sleep and cognitive interest persists, but evidence of benefit in humans remains limited.

At a glance

Pinealon Quick Reference

Community range
Members only
Sign in to view dosing details.
Cycle
Members only
Sign in to view dosing details.
Timing
Members only
Sign in to view dosing details.
Research focus
Neural resilience
Cognition, oxidative stress, and sleep interest
Overview

What Is Pinealon?

Pinealon is a synthetic three-amino-acid peptide with the sequence glutamic acid–aspartic acid–arginine (EDR). It belongs to the short peptide bioregulator family studied largely by Russian research groups.

Researchers have explored Pinealon in cell and animal models of neural stress, aging, and cognition. Its small size and proposed effects on gene expression make it an interesting research compound, but these mechanisms do not establish clinical benefit.

Community interest centers on sleep, circadian rhythm, and mental clarity. Those outcomes have not been validated in modern randomized human trials, and nasal and SubQ use should be considered distinct routes.

For other neuropeptide guides, see Cerebrolysin and Dihexa.

Mechanism

Pinealon Mechanism of Action

EDR tripeptide

The glutamic acid–aspartic acid–arginine sequence is a very short peptide studied as a bioregulator.

Cellular signaling

Laboratory studies investigate how EDR may interact with gene expression and stress-response pathways.

Neural stress models

Preclinical work explores oxidative-stress defense and neuronal survival, without establishing human neuroprotection.

Clinical translation

The link from these molecular observations to human cognition, REM sleep, or circadian outcomes remains unproven.

Research findings

Pinealon Benefits

Most reported benefits come from cell and animal research or community observation, rather than controlled human outcomes.

Neural Resilience

Cell experiments found less oxidative-stress-related cell death. The result does not establish neuroprotection in people.

Cognitive Research

Animal studies have explored learning and orientation; controlled human cognitive testing is lacking.

Sleep & REM Interest

Some community trackers report changes in dreams or REM estimates, without a controlled sleep-stage study.

Oxidative-Stress Models

Cell studies examine damage markers and stress-response signaling; the clinical importance remains uncertain.

Protocol planning

Pinealon Dosing Protocol

Members Access Only

Sign in or create a free account to view this content.

Preparation

Pinealon Reconstitution & Nasal Preparation

Nasal spray preparation example

10mg Pinealon in 5mL final volume

At 0.1mL per spray200mcg/spray

Nasal preparation

1
Prepare

Our reported diluent preference is 50% sterile, preservative-free 0.9% saline and 50% bacteriostatic 0.9% sodium chloride. The bacteriostatic component contains a preservative. Use a suitable metered bottle and clean handling.

2
Measure the final mixture

The example contains 10mg Pinealon in 5mL final liquid volume, using equal parts of the two diluents: 2.5mL sterile saline and 2.5mL bacteriostatic sodium chloride. This gives 2mg/mL.

3
Confirm pump output

At a measured 0.1mL per spray, 2mg/mL delivers 200mcg per spray. Check the bottle specification and actual output; another pump volume changes the amount per spray.

4
Storage

Keep refrigerated and protected from light according to the formulation instructions. Record the prep date in your research journal.

Reconstitution Example

10mg vial + 2mL bacteriostatic water

Result5mg/mL

Reconstitution steps

1
Prepare

Wash your hands, clean the work surface, and wipe both vial stoppers with alcohol. Allow them to dry.

2
Add diluent slowly

Use a new sterile syringe and needle to direct the selected volume of compatible diluent down the inside wall of the vial.

3
Dissolve gently

Swirl or roll the vial until the contents dissolve; do not shake.

4
Storage

Store refrigerated at 2–8°C (36–46°F) and protected from light when the product instructions support this. Record the reconstitution date in your research journal.

N=1 reports

Pinealon Community Experience

Self-reported anecdotal experiences aggregated from public & private peptide community discussions and anonymous peptideprotocols.app user reports. This information does not carry the same weight as published research.

Positive Reports

  • Some report clearer thinking or steadier focus during a short cycle.
  • Vivid dreams and apparent REM changes appear in wearable-tracked anecdotes.
  • Morning use is often preferred by those who notice sleep disruption later in the day.

Negative & Mixed Reports

  • Many people notice little or no meaningful difference.
  • Some report headache, anxiety, fatigue, dizziness, or disturbed sleep.
  • Wearable REM estimates may change without a corresponding improvement in restfulness.
Stacking & synergy

Pinealon Stacking & Synergy

These are community comparisons and research-interest pairings; combined effects have not been established.

Pinealon + Epitalon

Both appear in circadian and aging discussions. Tracking each separately makes it easier to tell whether Pinealon adds anything to the experience.

Pinealon + Semax

A cognitive-interest pairing: Semax is discussed for focus, while Pinealon is positioned as slower background neural support.

Pinealon + Selank

Selank appears in stress and calm-focus discussions. Any subjective change in a combination would be difficult to attribute.

Pinealon + Adamax

Adamax is commonly sought for a more noticeable cognitive experience; Pinealon’s effects, if any, may be subtler.

Safety notes

Pinealon Side Effects & Safety

Published human safety data are sparse. Neither a reliable adverse-event rate nor long-term safety profile has been established.

Community Reports

  • Headache, vivid dreams, or sleep disruption with later dosing.
  • Occasional anxiety, fatigue, or dizziness.
  • Injection-site irritation with SubQ use.

Unresolved Risks

  • A small uncontrolled report involving Pinealon and Vesugen described prooxidant activity and lower CD34+ blood-cell markers; it cannot isolate Pinealon’s effect.
  • Nasal product quality, spray calibration, and injectable sterility vary.
  • Effects with long-term or repeated cycles have not been adequately studied.

Pinealon Precautions

Avoid or Discuss With a Clinician If
  • Known hypersensitivity to Pinealon or a formulation ingredient.
  • Pregnancy or breastfeeding, where safety information is absent.
  • Existing neurologic or blood-related illness requiring established care.
Use Caution With
  • Serotonergic medications, because formal interaction studies are lacking.
  • Unverified nasal pump output or injectable product quality.
  • Assuming that nasal and SubQ amounts produce equivalent exposure.
Pinealon is not FDA approved for a human therapeutic indication.
Final verdict

Peptide Protocols Verdict on Pinealon

Not medical advice. This editorial is our own opinion piece based off the experience of our own lab rats.
Our opinionated opinion

We have tried Pinealon twice. The first nasal cycle produced no noticeable change in sleep, mood, or cognition. For the second, we moved dosing to the morning, got sunlight afterward, and tracked sleep with an Oura ring. REM estimates increased a little and dreams were more vivid, but we did not feel better rested or notice a meaningful cognitive lift.

That leaves us mixed and leaning toward a skip. The research idea is interesting, yet the result in our own experience was too subtle to justify much enthusiasm. For sleep and circadian interest we would look at Epitalon first; for a more noticeable cognitive experiment, Adamax. Pinealon keeps its C grade because the theory is stronger than our practical result.